BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 30343038)

  • 1. Beta-caryophyllene protects against diet-induced dyslipidemia and vascular inflammation in rats: Involvement of CB2 and PPAR-γ receptors.
    Youssef DA; El-Fayoumi HM; Mahmoud MF
    Chem Biol Interact; 2019 Jan; 297():16-24. PubMed ID: 30343038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-caryophyllene alleviates diet-induced neurobehavioral changes in rats: The role of CB2 and PPAR-γ receptors.
    Youssef DA; El-Fayoumi HM; Mahmoud MF
    Biomed Pharmacother; 2019 Feb; 110():145-154. PubMed ID: 30469079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. β-Caryophyllene, a natural bicyclic sesquiterpene attenuates doxorubicin-induced chronic cardiotoxicity via activation of myocardial cannabinoid type-2 (CB
    Meeran MFN; Al Taee H; Azimullah S; Tariq S; Adeghate E; Ojha S
    Chem Biol Interact; 2019 May; 304():158-167. PubMed ID: 30836069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. β-Caryophyllene Mitigates Collagen Antibody Induced Arthritis (CAIA) in Mice Through a Cross-Talk between CB2 and PPAR-γ Receptors.
    Irrera N; D'Ascola A; Pallio G; Bitto A; Mazzon E; Mannino F; Squadrito V; Arcoraci V; Minutoli L; Campo GM; Avenoso A; Bongiorno EB; Vaccaro M; Squadrito F; Altavilla D
    Biomolecules; 2019 Jul; 9(8):. PubMed ID: 31370242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promising neuroprotective effects of β-caryophyllene against LPS-induced oligodendrocyte toxicity: A mechanistic study.
    Askari VR; Shafiee-Nick R
    Biochem Pharmacol; 2019 Jan; 159():154-171. PubMed ID: 30529211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The protective effects of β-caryophyllene on LPS-induced primary microglia M
    Askari VR; Shafiee-Nick R
    Life Sci; 2019 Feb; 219():40-73. PubMed ID: 30620895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. β-Caryophyllene inhibits dextran sulfate sodium-induced colitis in mice through CB2 receptor activation and PPARγ pathway.
    Bento AF; Marcon R; Dutra RC; Claudino RF; Cola M; Leite DF; Calixto JB
    Am J Pathol; 2011 Mar; 178(3):1153-66. PubMed ID: 21356367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. β-Caryophyllene protects against alcoholic steatohepatitis by attenuating inflammation and metabolic dysregulation in mice.
    Varga ZV; Matyas C; Erdelyi K; Cinar R; Nieri D; Chicca A; Nemeth BT; Paloczi J; Lajtos T; Corey L; Hasko G; Gao B; Kunos G; Gertsch J; Pacher P
    Br J Pharmacol; 2018 Jan; 175(2):320-334. PubMed ID: 28107775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. β-Caryophyllene, a natural bicyclic sesquiterpene attenuates β-adrenergic agonist-induced myocardial injury in a cannabinoid receptor-2 dependent and independent manner.
    Meeran MFN; Laham F; Azimullah S; Sharma C; Al Kaabi AJ; Tariq S; Adeghate E; Goyal SN; Ojha S
    Free Radic Biol Med; 2021 May; 167():348-366. PubMed ID: 33588052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-Caryophyllene Modifies Intracellular Lipid Composition in a Cell Model of Hepatic Steatosis by Acting through CB2 and PPAR Receptors.
    Scandiffio R; Bonzano S; Cottone E; Shrestha S; Bossi S; De Marchis S; Maffei ME; Bovolin P
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. (-)-β-Caryophyllene, a CB2 Receptor-Selective Phytocannabinoid, Suppresses Motor Paralysis and Neuroinflammation in a Murine Model of Multiple Sclerosis.
    Alberti TB; Barbosa WL; Vieira JL; Raposo NR; Dutra RC
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28368293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polypharmacological Properties and Therapeutic Potential of β-Caryophyllene: A Dietary Phytocannabinoid of Pharmaceutical Promise.
    Sharma C; Al Kaabi JM; Nurulain SM; Goyal SN; Kamal MA; Ojha S
    Curr Pharm Des; 2016; 22(21):3237-64. PubMed ID: 26965491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A focused review on CB2 receptor-selective pharmacological properties and therapeutic potential of β-caryophyllene, a dietary cannabinoid.
    Hashiesh HM; Sharma C; Goyal SN; Sadek B; Jha NK; Kaabi JA; Ojha S
    Biomed Pharmacother; 2021 Aug; 140():111639. PubMed ID: 34091179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. β-Caryophyllene ameliorates the Alzheimer-like phenotype in APP/PS1 Mice through CB2 receptor activation and the PPARγ pathway.
    Cheng Y; Dong Z; Liu S
    Pharmacology; 2014; 94(1-2):1-12. PubMed ID: 25171128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic Potential of β-Caryophyllene: A Dietary Cannabinoid in Diabetes and Associated Complications.
    Hashiesh HM; Meeran MFN; Sharma C; Sadek B; Kaabi JA; Ojha SK
    Nutrients; 2020 Sep; 12(10):. PubMed ID: 32998300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental Cannabinoid 2 Receptor Activation by Phyto-Derived and Synthetic Cannabinoid Ligands in LPS-Induced Interstitial Cystitis in Mice.
    Berger G; Arora N; Burkovskiy I; Xia Y; Chinnadurai A; Westhofen R; Hagn G; Cox A; Kelly M; Zhou J; Lehmann C
    Molecules; 2019 Nov; 24(23):. PubMed ID: 31766439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute administration of beta-caryophyllene prevents endocannabinoid system activation during transient common carotid artery occlusion and reperfusion.
    Poddighe L; Carta G; Serra MP; Melis T; Boi M; Lisai S; Murru E; Muredda L; Collu M; Banni S; Quartu M
    Lipids Health Dis; 2018 Feb; 17(1):23. PubMed ID: 29402275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-Oleoylethanolamine Reduces Inflammatory Cytokines and Adhesion Molecules in TNF-α-induced Human Umbilical Vein Endothelial Cells by Activating CB2 and PPAR-α.
    Xu X; Guo H; Jing Z; Yang L; Chen C; Peng L; Wang X; Yan L; Ye R; Jin X; Wang Y
    J Cardiovasc Pharmacol; 2016 Oct; 68(4):280-291. PubMed ID: 27281236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiallodynic effect of β-caryophyllene on paclitaxel-induced peripheral neuropathy in mice.
    Segat GC; Manjavachi MN; Matias DO; Passos GF; Freitas CS; Costa R; Calixto JB
    Neuropharmacology; 2017 Oct; 125():207-219. PubMed ID: 28729222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective Effects of (
    Scandiffio R; Geddo F; Cottone E; Querio G; Antoniotti S; Gallo MP; Maffei ME; Bovolin P
    Nutrients; 2020 Oct; 12(11):. PubMed ID: 33114564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.